January 11, 2023
To,
The Manager
Listing Department,
The National Stock Exchange of India Limited
Exchange Plaza,
Bandra Kurla Complex,
Bandra (E), Mumbai - 400051
Dear Sir/ Madam,
Trading Symbol: ZOTA
Sub: Outcome of Board Meeting held on Wednesday, January 11, 2023
Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
With reference to the captioned subject, we Zota Health Care Limited (the "Company") would like to inform you that the Board of Directors of the Company in its Meeting held on Wednesday, January 11, 2023 at 11:00 A.M. at the registered office of the Company situated at Zota House, 2/896, Hira Modi Street, Sagrampura, Surat - 395002, Gujarat, have inter alia, discussed and approved the following businesses:
1. Appointment of Dr. Sujit Paul as Group Chief Executive Officer and Key Managerial Personnel
Appointed Dr. Sujit Paul as Group Chief Executive Officer (CEO) and Key Managerial Personnel of the Company w.e.f. January 16, 2023. He is going to take an important leadership role in the Company and will also play vital role in escalating and managing Davaindia project.
Brief Profile - Dr. Sujit Paul
Dr. Sujit Paul, carries over 20+ years of experience in multi-national, large and medium sized organizations in various corporate cultures and had played instrumental and strategic role in Retail, Hospitals, Health and Wellness sectors. Keeping health care sector at helm during his last association with Reliance Retail Limited (a subsidiary of Reliance Industries Limited), he has headed offline Retail Pharmacy right from inception to setting up pharmacy chain. He has also headed and handled
workforce of more than 5000+ people during his last association with Reliance Retail Limited. He has
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email:info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352
Page 1 of 5
also having track record of rolling out 1000 Pharmacies during his association with Apollo Pharmacy
Retail - Unit of Apollo Hospitals Ent Ltd.
He has done Bachelor of Science Honours from City College, Calcutta University. He has also done QMC, Quality Management from Philips Crossby Institute and Masters of Business Administration (MBA) IMT, Gaziabad and subsequently Doctorate in Management from ISBM.
Proven leader and part of Top Management with board level experience, Dr. Sujit Paul, has worked for diverse organizations such as Retail, Hospitals, Health and Wellness industries. With his broad array of experience, Dr. Paul has an extensive exposure to multi-nationalas well as large and medium-sizedorganizations in various corporate culture such as Reliance Retail Limited as Vice President and Business Head of B2C, Retail Pharmacy, Hospital and New Projects, StayHappi as a Managing Director, Columbia Asia Hospitals Pvt. Ltd. as a Vice President, Trust Chemist and Drugist Ltd. - Retail and Online Wellness and Pharmacy Chain as a Sr. Vice President, Emeditek Services Limited as a Sr. Vice President, Apollo Pharmacy Retail as General Manager, City Info Services Pvt. Ltd. as General Manager, Chandras Chemicals Ent Ltd. as a Head Marketing (Product Manager), Kodiak India Ltd. as a Photoshop Coordinator, Bata India Ltd. as a District Manager and as a Territory Sales in charge at Asian Paints.
Other than a thriving professional life, Dr. Sujit Paul enjoys reading, travelling and is a global mentor. He is a believer of ground-level realities and possesses a strong team building attitude. He is also an acclaimed public speaker and is an author.
We further confirm that he is not related to any of the Directors of the Company.
2. Considered and Approved:
- Zota Health Care - Employee Stock Option Plan 2022;
-
To extend 'Zota Health Care - Employee Stock Option Plan 2022' to the employees of
Holding Company, its Subsidiary Company (ies) and/ or Associate Company(ies), Group Company(ies) [present and future].
The aforementioned approvals are subject to the member's approval and for the same the
Board has decided to take the approval through Postal Ballot, by way of remote e-voting only; The Board has approved following matters for the Postal Ballot process:
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email:info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352
Page 2 of 5
- Approved the Notice of Postal Ballot.
- Decided Friday, January 13, 2023 as Cut-off date for ascertaining the list of Shareholders to whom notice of Postal Ballot will be sent and also for reckoning voting rights.
- Considered and approved appointment of Mr. Ranjit B. Kejriwal, Practicing Company Secretary as Scrutinizer for conducting Postal Ballot.
- Approved Calendar of events for the Postal Ballot. The same are as per Annexure - I.
The Disclosures pursuant to SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 for the issuance of securities under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached. (Annexure-II)
The Board meeting concluded at 12:55 P.M.
This is for your information and record.
Thanking you,
Yours faithfully,
For Zota Health Care Limited
ASHVIN BHAGAVANB HAI VARIYA
Digitally signed by ASHVIN BHAGAVANBHAI VARIYA DN: c=IN, postalCode=395005, st=GUJARAT, street=BUILDING C4 FLAT NO. 1304 NAKSHATRA NEBULA ,SURAT,JAHANGIRABAD ,395005, l=SURAT, o=Personal, serialNumber=8b7b8f5ffa7f37759537cc6802d2d91bcf 752aeea3849601fe08d8642c00cdee, pseudonym=7bf90549ac6644dd9c7b7d848263ee48, 2.5.4.20=cbc64db43adf7de082771bc68bf88f8bc285d 4a88a95356c6aac28e940def5c7, email=VARIYA.ASHVIN@YAHOO.IN, cn=ASHVIN
BHAGAVANBHAI VARIYA
Date: 2023.01.11 13:08:07 +05'30'
Ashvin Variya
(Company Secretary & Compliance Officer)
Place: Surat
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email:info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352
Page 3 of 5
Annexure - I:
Calendar of Events for Postal Ballot
Event | Date (DD/MM/YYYY) and Day |
Intimation of Board Meeting | 03.01.2023 Tuesday |
Date on which consent is given by the Scrutinizer | 03.01.2023 Tuesday |
Outcome of Board Meeting | 11.01.2023 Wednesday |
Date of Appointment of Scrutinizer | 11.01.2023 Wednesday |
Date of Board Resolution authorizing postal ballot notice | 11.01.2023 Wednesday |
Submission of Calendar of Events to Stock Exchange, RTA & | 11.01.2023 Wednesday |
Depositories | |
Creation of EVEN for e-voting | 13.01.2023 Friday |
Cut-off date for deciding voting rights of the Shareholders | 13.01.2023 Friday |
Proposed date of Dispatch of Notice of Postal Ballot | 16.01.2023 Monday |
Completion of Dispatch of Notice of Postal Ballot | 16.01.2023 Monday |
Newspaper advertisement for Postal Ballot and e-voting | 17.01.2023 Tuesday |
Submission of Newspaper advertisement to the Stock Exchange | 17.01.2023 Tuesday |
Commencement of Postal Ballot, by way of remote e-voting only | 19.01.2023 Thursday at 9:00 A.M. |
Conclusion of Postal Ballot, by way of remote e-voting only | 17.02.2023 Friday at 05:00 P.M. |
Last date for casting vote through remote e-voting | 17.02.2023 Friday TILL 05:00 P.M. |
Resolution Passed Date (deemed general meeting) | 17.02.2023 Friday |
Receipt of the Scrutinizer Report | 18.02.2023 Saturday |
Declaration of Results by the Chairman/ Company Secretary | 19.02.2023 Sunday |
Submission of Voting Results to the Stock Exchange | 19.02.2023 Sunday |
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email:info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352
Page 4 of 5
Annexure - II
Disclosure pursuant to SEBI Circular CIR/CFD/CMD/4/2015 dated 9th September, 2015 for the issuance of securities under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Sr. No. | Particulars | Remark |
1 | Name of the Scheme | 'Zota Health Care - Employee Stock Option Plan 2022' |
2 | Brief details of options granted | The total number of Options to be granted under the |
Scheme shall not exceed 2,50,000 (Two Lakhs Fifty | ||
Thousand) equity shares of Rs. 10/- each. | ||
The Scheme will be implemented directly by the | ||
Company under the guidance of the Board of Directors/ | ||
its Compensation / Nomination and Remuneration | ||
Committee. | ||
3 | Whether the scheme is in terms of | Yes |
SEBI (SBEB and Sweat Equity) | ||
Regulations, 2021 | ||
4 | Pricing Formula | Exercise Price shall be as may be decided by the Board/ |
Committee as is allowed under the Companies Act, | ||
2013 and SEBI (SBEB and Sweat Equity) Regulations, | ||
2021 which in any case will not be lower than the face | ||
value of the equity Shares of the Company on the date | ||
of such grant. Further the Exercise Price can be | ||
different for different set of Employees for Options | ||
granted on same / different dates. | ||
5 | Brief details of significant terms | The vesting period shall be decided by the |
Compensation/ Nomination and Remuneration | ||
Committee from time to time but shall not be less than | ||
one year and more than seven years from the grant of | ||
options. | ||
6 | Provision of loan to the ESOP Trust | Not Applicable |
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email:info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352
Page 5 of 5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Zota Health Care Ltd. published this content on 11 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 January 2023 08:40:29 UTC.